328 related articles for article (PubMed ID: 27693737)
1. Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells.
Safwat MA; Soliman GM; Sayed D; Attia MA
Int J Pharm; 2016 Nov; 513(1-2):648-658. PubMed ID: 27693737
[TBL] [Abstract][Full Text] [Related]
2. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model.
Safwat MA; Soliman GM; Sayed D; Attia MA
Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979
[TBL] [Abstract][Full Text] [Related]
3. Gold nanoparticles capped with benzalkonium chloride and poly (ethylene imine) for enhanced loading and skin permeability of 5-fluorouracil.
Safwat MA; Soliman GM; Sayed D; Attia MA
Drug Dev Ind Pharm; 2017 Nov; 43(11):1780-1791. PubMed ID: 28581826
[TBL] [Abstract][Full Text] [Related]
4. Pluronic-Coated Biogenic Gold Nanoparticles for Colon Delivery of 5-Fluorouracil: In vitro and Ex vivo Studies.
Mahdi WA; Hussain A; Ramzan M; Faruk A; Bukhari SI; Dev A
AAPS PharmSciTech; 2021 Feb; 22(2):64. PubMed ID: 33533992
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil monodispersed chitosan microspheres: Microfluidic chip fabrication with crosslinking, characterization, drug release and anticancer activity.
He T; Wang W; Chen B; Wang J; Liang Q; Chen B
Carbohydr Polym; 2020 May; 236():116094. PubMed ID: 32172896
[TBL] [Abstract][Full Text] [Related]
6. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
7. Hydrophilic drug encapsulation in shell-core microcarriers by two stage polyelectrolyte complexation method.
Dalmoro A; Sitenkov AY; Cascone S; Lamberti G; Barba AA; Moustafine RI
Int J Pharm; 2017 Feb; 518(1-2):50-58. PubMed ID: 28034735
[TBL] [Abstract][Full Text] [Related]
8. Glutathione-mediated drug release from Tiopronin-conjugated gold nanoparticles for acute liver injury therapy.
Bao QY; Geng DD; Xue JW; Zhou G; Gu SY; Ding Y; Zhang C
Int J Pharm; 2013 Mar; 446(1-2):112-8. PubMed ID: 23416166
[TBL] [Abstract][Full Text] [Related]
9. Self-healable hydrogel on tumor cell as drug delivery system for localized and effective therapy.
Chang G; Chen Y; Li Y; Li S; Huang F; Shen Y; Xie A
Carbohydr Polym; 2015 May; 122():336-42. PubMed ID: 25817677
[TBL] [Abstract][Full Text] [Related]
10. Encapsulation and Systemic Delivery of 5-Fluorouracil Conjugated with Silkworm Pupa Derived Protein Nanoparticles for Experimental Lymphoma Cancer.
Reneeta NP; Thiyonila B; Aathmanathan VS; Ramya T; Chandrasekar P; Subramanian N; Prajapati VK; Krishnan M
Bioconjug Chem; 2018 Sep; 29(9):2994-3009. PubMed ID: 30089206
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Two Approaches for the Attachment of a Drug to Gold Nanoparticles and Their Anticancer Activities.
Fu Y; Feng Q; Chen Y; Shen Y; Su Q; Zhang Y; Zhou X; Cheng Y
Mol Pharm; 2016 Sep; 13(9):3308-17. PubMed ID: 27518201
[TBL] [Abstract][Full Text] [Related]
12. Oxidation and pH responsive nanoparticles based on ferrocene-modified chitosan oligosaccharide for 5-fluorouracil delivery.
Xu Y; Wang L; Li YK; Wang CQ
Carbohydr Polym; 2014 Dec; 114():27-35. PubMed ID: 25263860
[TBL] [Abstract][Full Text] [Related]
13. Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide.
Di Martino A; Pavelkova A; Maciulyte S; Budriene S; Sedlarik V
Eur J Pharm Sci; 2016 Sep; 92():276-86. PubMed ID: 27154260
[TBL] [Abstract][Full Text] [Related]
14. The Potential Anticancer Activity of 5-Fluorouracil Loaded in Cellulose Fibers Isolated from Rice Straw.
Yusefi M; Shameli K; Jahangirian H; Teow SY; Umakoshi H; Saleh B; Rafiee-Moghaddam R; Webster TJ
Int J Nanomedicine; 2020; 15():5417-5432. PubMed ID: 32801697
[TBL] [Abstract][Full Text] [Related]
15. Conjugating folic acid to gold nanoparticles through glutathione for targeting and detecting cancer cells.
Zhang Z; Jia J; Lai Y; Ma Y; Weng J; Sun L
Bioorg Med Chem; 2010 Aug; 18(15):5528-34. PubMed ID: 20621495
[TBL] [Abstract][Full Text] [Related]
16. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronidase Enzyme-responsive Targeted Nanoparticles for Effective Delivery of 5-Fluorouracil in Colon Cancer.
Jiang H; Shi X; Yu X; He X; An Y; Lu H
Pharm Res; 2018 Feb; 35(4):73. PubMed ID: 29476264
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro evaluation of 5-flourouracil loaded magnetite-zeolite nanocomposite (5-FU-MZNC) for cancer drug delivery applications.
Sağir T; Huysal M; Durmus Z; Kurt BZ; Senel M; Isık S
Biomed Pharmacother; 2016 Feb; 77():182-90. PubMed ID: 26796283
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.
Li S; Wang A; Jiang W; Guan Z
BMC Cancer; 2008 Apr; 8():103. PubMed ID: 18412945
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Rajan M; Raj V; Al-Arfaj AA; Murugan AM
Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
